ASR Nederland stock holds on earnings and capital strength

ASR Nederland (NL0011872643) stock is anchored by a reported EUR 1.3 billion net profit for 2025, a 203% Solvency II ratio at year-end 2025, and a market capitalization that stood at EUR 8.1 billion on 17 July 2026. The company said the 2025 outcome was supported by a 14% rise in operating capital generation to EUR 1.1 billion, which gives the shares a clear earnings and balance-sheet reference point.

EUR 1.3 billion net profit

ASR Nederland reported a net profit of EUR 1.3 billion for 2025, compared with EUR 1.0 billion in 2024, according to its annual reporting context. That is a year-on-year increase of about 30%, and it matters because the profit step-up came alongside a higher capital ratio rather than at the expense of solvency.

The same 2025 reporting set also showed operating capital generation of EUR 1.1 billion, up 14% from the prior year. For an insurer, that combination of profit growth and capital generation is more relevant than a one-off quarterly swing, because it feeds dividend capacity and balance-sheet flexibility.

Solvency at 203%

The 203% Solvency II ratio at 31 December 2025 remains the key capital metric for ASR Nederland. The ratio gives the market a buffer reference point above regulatory minimums, and it is a useful marker for how much room the insurer has for underwriting discipline, capital return, and reinvestment.

On 17 July 2026, the company was valued at roughly EUR 8.1 billion in market capitalization. Against EUR 1.3 billion of 2025 net profit, that scale suggests investors are still pricing the stock primarily on capital durability and earnings quality rather than on a single headline growth rate.

Insurance profit mix

The latest figures suggest the business mix is still doing the work. A 2025 operating capital generation figure of EUR 1.1 billion, together with EUR 1.3 billion of net profit, points to an insurer that is not relying on a single segment to carry the full result.

That matters for ASR Nederland stock because insurers are often valued on consistency in underwriting, investment income, and capital release rather than on rapid top-line expansion. The reported 14% increase in operating capital generation therefore carries more weight than a headline revenue number would in another sector.

2025 profit up 30%

The 2025 profit increase from EUR 1.0 billion to EUR 1.3 billion is the most direct quantified comparison in the current data set. It gives investors a clear yardstick for how the insurer performed versus the prior year, and it also provides a baseline for future capital-return expectations.

The 203% Solvency II ratio at 31 December 2025 adds a second comparison point, because it shows the company entering 2026 with substantial capital cover. In insurer coverage, that combination of higher profit and a strong solvency ratio usually matters more than short-term trading sentiment.

Dividend lens matters

For ASR Nederland, the representative product is straightforward: insurance and pension solutions sold through a broad Dutch retail and institutional franchise. Those core lines are the source of the capital and profit figures that matter most in the stock story.

The 2025 annual results imply that the insurer's core offering remained profitable enough to support a solid capital outcome. That is the operational backbone behind the valuation reference, not a standalone product launch or consumer-brand story.

Market value and shares

ASR Nederland stock was valued at about EUR 8.1 billion on 17 July 2026, which gives the company a mid-cap footprint in European financials. The valuation sits alongside a 2025 net profit of EUR 1.3 billion and a 203% Solvency II ratio, leaving the market to weigh durability rather than surprise.

For current pricing, the relevant stock market reference is the latest dated market value rather than a live quote in this text. The shares are framed by the same year-end 2025 capital base and the 17 July 2026 valuation point, which keeps the comparison anchored in evidenced numbers.